Teva Pharmaceutical Industries Limited (TEVA)
USD 16.1
(9.75%)
USD 16.1
(9.75%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.64 Billion USD | 9.64% |
| 2022 | 6.97 Billion USD | -8.18% |
| 2021 | 7.59 Billion USD | -1.7% |
| 2020 | 7.72 Billion USD | 2.51% |
| 2019 | 7.53 Billion USD | -9.16% |
| 2018 | 8.29 Billion USD | -23.36% |
| 2017 | 10.82 Billion USD | -8.72% |
| 2016 | 11.85 Billion USD | 4.43% |
| 2015 | 11.35 Billion USD | 2.71% |
| 2014 | 11.05 Billion USD | 3.26% |
| 2013 | 10.7 Billion USD | 0.52% |
| 2012 | 10.65 Billion USD | 11.95% |
| 2011 | 9.51 Billion USD | 4.96% |
| 2010 | 9.06 Billion USD | 23.05% |
| 2009 | 7.36 Billion USD | 23.44% |
| 2008 | 5.96 Billion USD | 22.37% |
| 2007 | 4.87 Billion USD | 14.51% |
| 2006 | 4.25 Billion USD | 71.69% |
| 2005 | 2.48 Billion USD | 10.78% |
| 2004 | 2.23 Billion USD | 47.43% |
| 2003 | 1.51 Billion USD | 38.66% |
| 2002 | 1.09 Billion USD | 29.28% |
| 2001 | 847.29 Million USD | 7.68% |
| 2000 | 786.86 Million USD | 34.92% |
| 1999 | 583.2 Million USD | 21.55% |
| 1998 | 479.8 Million USD | -1.68% |
| 1997 | 488 Million USD | 20.97% |
| 1996 | 403.4 Million USD | 32.87% |
| 1995 | 303.6 Million USD | 7.66% |
| 1994 | 282 Million USD | 20.77% |
| 1993 | 233.5 Million USD | 32.0% |
| 1992 | 176.9 Million USD | 33.01% |
| 1991 | 133 Million USD | -3.41% |
| 1990 | 137.7 Million USD | 37.15% |
| 1989 | 100.4 Million USD | 23.04% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.78 Billion USD | -26.16% |
| 2024 Q2 | 2.02 Billion USD | 13.34% |
| 2023 Q2 | 1.79 Billion USD | 13.53% |
| 2023 Q1 | 1.58 Billion USD | -10.67% |
| 2023 FY | 7.64 Billion USD | 9.64% |
| 2023 Q4 | 2.41 Billion USD | 30.52% |
| 2023 Q3 | 1.85 Billion USD | 3.06% |
| 2022 Q3 | 1.66 Billion USD | -6.92% |
| 2022 Q1 | 1.74 Billion USD | -15.16% |
| 2022 FY | 6.97 Billion USD | -8.18% |
| 2022 Q2 | 1.79 Billion USD | 3.05% |
| 2022 Q4 | 1.77 Billion USD | 6.11% |
| 2021 Q3 | 1.79 Billion USD | -4.27% |
| 2021 FY | 7.59 Billion USD | -1.7% |
| 2021 Q2 | 1.87 Billion USD | -0.27% |
| 2021 Q4 | 2.05 Billion USD | 14.39% |
| 2021 Q1 | 1.87 Billion USD | -8.26% |
| 2020 FY | 7.72 Billion USD | 2.51% |
| 2020 Q3 | 1.85 Billion USD | 5.05% |
| 2020 Q4 | 2.04 Billion USD | 10.53% |
| 2020 Q2 | 1.76 Billion USD | -14.54% |
| 2020 Q1 | 2.06 Billion USD | 5.36% |
| 2019 Q2 | 1.89 Billion USD | 2.1% |
| 2019 FY | 7.53 Billion USD | -9.16% |
| 2019 Q1 | 1.85 Billion USD | -5.89% |
| 2019 Q3 | 1.82 Billion USD | -3.43% |
| 2019 Q4 | 1.95 Billion USD | 7.05% |
| 2018 FY | 8.29 Billion USD | -23.36% |
| 2018 Q1 | 2.34 Billion USD | -7.63% |
| 2018 Q2 | 2.06 Billion USD | -12.22% |
| 2018 Q4 | 1.97 Billion USD | -2.47% |
| 2018 Q3 | 2.02 Billion USD | -1.94% |
| 2017 Q2 | 2.82 Billion USD | 0.07% |
| 2017 Q4 | 2.54 Billion USD | -3.82% |
| 2017 Q3 | 2.64 Billion USD | -6.31% |
| 2017 FY | 10.82 Billion USD | -8.72% |
| 2017 Q1 | 2.81 Billion USD | -16.84% |
| 2016 FY | 11.85 Billion USD | 4.43% |
| 2016 Q1 | 2.79 Billion USD | -1.97% |
| 2016 Q2 | 2.87 Billion USD | 3.08% |
| 2016 Q3 | 2.8 Billion USD | -2.64% |
| 2016 Q4 | 3.39 Billion USD | 21.03% |
| 2015 Q4 | 2.84 Billion USD | 2.74% |
| 2015 FY | 11.35 Billion USD | 2.71% |
| 2015 Q3 | 2.77 Billion USD | -4.51% |
| 2015 Q2 | 2.9 Billion USD | 2.33% |
| 2015 Q1 | 2.83 Billion USD | -1.83% |
| 2014 Q3 | 2.8 Billion USD | 5.56% |
| 2014 FY | 11.05 Billion USD | 3.26% |
| 2014 Q1 | 2.69 Billion USD | -6.81% |
| 2014 Q2 | 2.66 Billion USD | -1.33% |
| 2014 Q4 | 2.88 Billion USD | 2.85% |
| 2013 Q3 | 2.63 Billion USD | 1.43% |
| 2013 FY | 10.7 Billion USD | 0.52% |
| 2013 Q1 | 2.59 Billion USD | -7.0% |
| 2013 Q2 | 2.59 Billion USD | 0.12% |
| 2013 Q4 | 2.89 Billion USD | 10.04% |
| 2012 Q1 | 2.6 Billion USD | -9.44% |
| 2012 Q4 | 2.78 Billion USD | 7.07% |
| 2012 Q3 | 2.6 Billion USD | -2.11% |
| 2012 Q2 | 2.65 Billion USD | 1.84% |
| 2012 FY | 10.65 Billion USD | 11.95% |
| 2011 FY | 9.51 Billion USD | 4.96% |
| 2011 Q4 | 2.88 Billion USD | 28.27% |
| 2011 Q1 | 2.18 Billion USD | -11.2% |
| 2011 Q2 | 2.2 Billion USD | 0.55% |
| 2011 Q3 | 2.24 Billion USD | 2.09% |
| 2010 Q1 | 2.01 Billion USD | -4.1% |
| 2010 FY | 9.06 Billion USD | 23.05% |
| 2010 Q4 | 2.46 Billion USD | -0.12% |
| 2010 Q3 | 2.46 Billion USD | 16.31% |
| 2010 Q2 | 2.12 Billion USD | 5.37% |
| 2009 Q2 | 1.76 Billion USD | 12.6% |
| 2009 Q1 | 1.57 Billion USD | -1.75% |
| 2009 FY | 7.36 Billion USD | 23.44% |
| 2009 Q3 | 1.92 Billion USD | 8.99% |
| 2009 Q4 | 2.09 Billion USD | 8.87% |
| 2008 Q2 | 1.5 Billion USD | 9.69% |
| 2008 Q4 | 1.59 Billion USD | 7.17% |
| 2008 FY | 5.96 Billion USD | 22.37% |
| 2008 Q1 | 1.37 Billion USD | 1.86% |
| 2008 Q3 | 1.49 Billion USD | -0.86% |
| 2007 Q4 | 1.34 Billion USD | 7.76% |
| 2007 Q1 | 1.03 Billion USD | -5.95% |
| 2007 FY | 4.87 Billion USD | 14.51% |
| 2007 Q2 | 1.24 Billion USD | 19.86% |
| 2007 Q3 | 1.25 Billion USD | 0.56% |
| 2006 Q3 | 1.26 Billion USD | 7.72% |
| 2006 Q1 | 723.4 Million USD | 6.93% |
| 2006 FY | 4.25 Billion USD | 71.69% |
| 2006 Q4 | 1.1 Billion USD | -12.61% |
| 2006 Q2 | 1.17 Billion USD | 61.92% |
| 2005 Q1 | 603.7 Million USD | -2.0% |
| 2005 Q4 | 676.5 Million USD | 9.36% |
| 2005 Q3 | 618.6 Million USD | 6.33% |
| 2005 Q2 | 581.8 Million USD | -3.63% |
| 2005 FY | 2.48 Billion USD | 10.78% |
| 2004 Q2 | 553.3 Million USD | 15.17% |
| 2004 FY | 2.23 Billion USD | 47.43% |
| 2004 Q4 | 616 Million USD | 4.48% |
| 2004 Q3 | 589.6 Million USD | 6.56% |
| 2004 Q1 | 480.4 Million USD | 10.95% |
| 2003 Q1 | 348.4 Million USD | 2.71% |
| 2003 Q4 | 433 Million USD | 14.79% |
| 2003 FY | 1.51 Billion USD | 38.66% |
| 2003 Q3 | 377.2 Million USD | 4.69% |
| 2003 Q2 | 360.3 Million USD | 3.42% |
| 2002 Q3 | 270.6 Million USD | 9.51% |
| 2002 Q2 | 247.1 Million USD | 3.61% |
| 2002 Q4 | 339.2 Million USD | 25.35% |
| 2002 Q1 | 238.5 Million USD | -0.58% |
| 2002 FY | 1.09 Billion USD | 29.28% |
| 2001 Q1 | 196.96 Million USD | -34.49% |
| 2001 Q3 | 205.7 Million USD | 0.47% |
| 2001 Q2 | 204.74 Million USD | 3.95% |
| 2001 FY | 847.29 Million USD | 7.68% |
| 2001 Q4 | 239.89 Million USD | 16.62% |
| 2000 Q1 | 137.58 Million USD | -37.77% |
| 2000 FY | 786.86 Million USD | 34.92% |
| 2000 Q3 | 180.33 Million USD | -6.51% |
| 2000 Q4 | 300.67 Million USD | 66.73% |
| 2000 Q2 | 192.89 Million USD | 40.2% |
| 1999 Q2 | 120.8 Million USD | 7.09% |
| 1999 Q1 | 112.8 Million USD | -35.76% |
| 1999 Q4 | 221.1 Million USD | 72.2% |
| 1999 FY | 583.2 Million USD | 21.55% |
| 1999 Q3 | 128.4 Million USD | 6.29% |
| 1998 Q1 | 98.1 Million USD | -66.39% |
| 1998 FY | 479.8 Million USD | -1.68% |
| 1998 Q2 | 88.7 Million USD | -9.58% |
| 1998 Q3 | 117.3 Million USD | 32.24% |
| 1998 Q4 | 175.6 Million USD | 49.7% |
| 1997 Q2 | 270.7 Million USD | 1.16% |
| 1997 FY | 488 Million USD | 20.97% |
| 1997 Q3 | 286.7 Million USD | 5.91% |
| 1997 Q4 | 291.9 Million USD | 1.81% |
| 1997 Q1 | 267.6 Million USD | -3.64% |
| 1996 Q4 | 277.7 Million USD | 17.37% |
| 1996 Q3 | 236.6 Million USD | -5.44% |
| 1996 Q2 | 250.2 Million USD | 32.17% |
| 1996 Q1 | 189.3 Million USD | -1.87% |
| 1996 FY | 403.4 Million USD | 32.87% |
| 1995 Q1 | 152.7 Million USD | -4.92% |
| 1995 Q3 | 165.3 Million USD | 5.42% |
| 1995 Q2 | 156.8 Million USD | 2.69% |
| 1995 FY | 303.6 Million USD | 7.66% |
| 1995 Q4 | 192.9 Million USD | 16.7% |
| 1994 Q1 | 136.7 Million USD | 4.11% |
| 1994 FY | 282 Million USD | 20.77% |
| 1994 Q4 | 160.6 Million USD | 11.92% |
| 1994 Q3 | 143.5 Million USD | -2.31% |
| 1994 Q2 | 146.9 Million USD | 7.46% |
| 1993 Q4 | 131.3 Million USD | 3.22% |
| 1993 Q3 | 127.2 Million USD | 1.76% |
| 1993 Q1 | 118.4 Million USD | -10.24% |
| 1993 FY | 233.5 Million USD | 32.0% |
| 1993 Q2 | 125 Million USD | 5.57% |
| 1992 Q4 | 131.9 Million USD | 41.83% |
| 1992 Q2 | 93 Million USD | 0.11% |
| 1992 Q1 | 92.9 Million USD | 12.33% |
| 1992 Q3 | 93 Million USD | 0.0% |
| 1992 FY | 176.9 Million USD | 33.01% |
| 1991 Q2 | 77.8 Million USD | -10.88% |
| 1991 Q4 | 82.7 Million USD | 5.08% |
| 1991 Q1 | 87.3 Million USD | -37.6% |
| 1991 Q3 | 78.7 Million USD | 1.16% |
| 1991 FY | 133 Million USD | -3.41% |
| 1990 FY | 137.7 Million USD | 37.15% |
| 1990 Q1 | 65.7 Million USD | -22.98% |
| 1990 Q2 | 69.6 Million USD | 5.94% |
| 1990 Q3 | 62.6 Million USD | -10.06% |
| 1990 Q4 | 139.9 Million USD | 123.48% |
| 1989 Q3 | 63.8 Million USD | -7.27% |
| 1989 Q2 | 68.8 Million USD | 0.88% |
| 1989 Q1 | 68.2 Million USD | 2.71% |
| 1989 Q4 | 85.3 Million USD | 33.7% |
| 1989 FY | 100.4 Million USD | 23.04% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 820.56 Million USD | -831.797% |
| Bausch Health Companies Inc. | 6.19 Billion USD | -23.362% |
| Catalent, Inc. | 953 Million USD | -702.308% |
| Emergent BioSolutions Inc. | 343.9 Million USD | -2123.321% |
| Elanco Animal Health Incorporated | 2.48 Billion USD | -207.562% |
| Perrigo Company plc | 1.68 Billion USD | -355.011% |
| Zoetis Inc. | 5.83 Billion USD | -31.059% |